UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mast cell activation symptoms are prevalent in Long-COVID

International journal of infectious diseases, 2021-11, Vol.112, p.217-226

2021

Volltextzugriff (PDF)

Familial occurrence of systemic mast cell activation disease

PloS one, 2013-09, Vol.8 (9), p.e76241-e76241

2013

Volltextzugriff (PDF)

Determination of plasma heparin level improves identification of systemic mast cell activation disease

PloS one, 2015-04, Vol.10 (4), p.e0124912

2015

Volltextzugriff (PDF)

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Internal Medicine, 2011, Vol.50(6), pp.611-615

2011

Volltextzugriff (PDF)

Restless legs syndrome is associated with long-COVID in women

Journal of clinical sleep medicine, 2022-05, Vol.18 (5), p.1413-1418

2022

Volltextzugriff (PDF)

New aspects of liver abnormalities as part of the systemic mast cell activation syndrome

Liver international, 2009-02, Vol.29 (2), p.181-186

2009

Volltextzugriff (PDF)

Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing

Immunogenetics (New York), 2017-06, Vol.69 (6), p.359-369

2017

Volltextzugriff (PDF)

Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease

Immunogenetics (New York), 2014-05, Vol.66 (5), p.287-297

2014

Volltextzugriff (PDF)

Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects

Immunogenetics (New York), 2010-12, Vol.62 (11-12), p.721-727

2010

Volltextzugriff (PDF)

Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations

Clinical breast cancer, 2018-06, Vol.18 (3), p.e271-e276

2018

Volltextzugriff (PDF)

Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling

Life sciences (1973), 2013-03, Vol.92 (6-7), p.345-351

2013

Volltextzugriff (PDF)

Bleeding diathesis in patients with mast cell activation disease

Thrombosis and haemostasis, 2011-11, Vol.106 (5), p.987-989

2011

Volltextzugriff (PDF)

Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases

Naunyn-Schmiedeberg's archives of pharmacology, 2013-09, Vol.386 (9), p.789-793

2013

Volltextzugriff (PDF)

Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study

Journal of translational medicine, 2014-08, Vol.12 (1), p.213, Article 213

2014

Volltextzugriff (PDF)

Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder

Scandinavian journal of gastroenterology, 2007-01, Vol.42 (9), p.1045-1053

2007

Volltextzugriff (PDF)

Regulatory mechanisms underlying agmatine homeostasis in humans

American journal of physiology: Gastrointestinal and liver physiology, 2008-11, Vol.295 (5), p.G1104-G1110

2008

Volltextzugriff (PDF)

Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics

Urolithiasis, 2009-08, Vol.37 (4), p.227-229

2009

Volltextzugriff (PDF)

Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor-specific mechanism

Hepatology (Baltimore, Md.), 2001-11, Vol.34 (5), p.884-888

2001

Volltextzugriff (PDF)

Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis

Gastroenterology (New York, N.Y. 1943), 1999-02, Vol.116 (2), p.387-393

1999

Volltextzugriff (PDF)

Re: Mastocytosis--a disease of the hematopoietic stem cell. Problematic criteria

Deutsches Ärzteblatt international, 2009-03, Vol.106 (10), p.173; author reply 173-173; author reply 174

2009

Volltextzugriff (PDF)

Species-specific pharmacological properties of human alpha(2A)-adrenoceptors

Hypertension (Dallas, Tex. 1979), 2000-09, Vol.36 (3), p.405-410

2000

Volltextzugriff (PDF)

Dysferlinopathy as an extrahepatic cause for the elevation of serum transaminases

Medizinische Klinik (München. 1983), 2004-06, Vol.99 (6), p.326-329

2004

Volltextzugriff (PDF)

Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors

Naunyn-Schmiedeberg's archives of pharmacology, 1998-10, Vol.358 (4), p.440-444

1998

Volltextzugriff (PDF)

Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3‐ and DP‐receptors

British journal of pharmacology, 1994-03, Vol.111 (3), p.733-738

1994

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mast cell activation symptoms are prevalent in Long-COVID

Familial occurrence of systemic mast cell activation disease

Determination of plasma heparin level improves identification of systemic mast cell activation disease

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Restless legs syndrome is associated with long-COVID in women

New aspects of liver abnormalities as part of the systemic mast cell activation syndrome

Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing

Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease

Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects

Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations

Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling

Bleeding diathesis in patients with mast cell activation disease

Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases

Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study

Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder

Regulatory mechanisms underlying agmatine homeostasis in humans

Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics

Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor-specific mechanism

Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis

Re: Mastocytosis--a disease of the hematopoietic stem cell. Problematic criteria

Species-specific pharmacological properties of human alpha(2A)-adrenoceptors

Dysferlinopathy as an extrahepatic cause for the elevation of serum transaminases

Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors

Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3‐ and DP‐receptors

Aktive Filter

Suchergebnisse filtern